Thomas Anderson
Director · ZEVRA THERAPEUTICS, INC.
Individual
- 2026
- Jun 18, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas Anderson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil F. McFarlane - $1.20M in ZVRA purchases and sales in the last 12 months
- Rahsaan Thompson - $969K in ZVRA purchases and sales in the last 12 months
- Corey Michael Watton - $138K in ZVRA purchases and sales in the last 12 months
- Joshua Schafer - $126K in ZVRA purchases and sales in the last 12 months
- Timothy J. Sangiovanni - $43K in ZVRA purchases and sales in the last 12 months
- Adrian W. Quartel - $40K in ZVRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas Anderson?
Thomas Anderson is a corporate insider, tracked as Director of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Thomas Anderson last file a Form 4?
The only primary Form 4 on record is dated 18 June 2026.